Growth Metrics

Valion Bio (TIVC) Change in Account Payables (2021 - 2025)

Valion Bio has reported Change in Account Payables over the past 5 years, most recently at -$201000.0 for Q4 2025.

  • For Q4 2025, Change in Account Payables rose 3.37% year-over-year to -$201000.0; the TTM value through Dec 2025 reached $139000.0, up 123.64%, while the annual FY2025 figure was $139000.0, 123.64% up from the prior year.
  • Change in Account Payables for Q4 2025 was -$201000.0 at Valion Bio, down from $231000.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $1.3 million in Q2 2022 and troughed at -$510000.0 in Q4 2021.
  • A 5-year average of -$5300.0 and a median of -$164500.0 in 2022 define the central range for Change in Account Payables.
  • Biggest five-year swings in Change in Account Payables: tumbled 377.33% in 2024 and later surged 304.42% in 2025.
  • Year by year, Change in Account Payables stood at -$510000.0 in 2021, then surged by 45.29% to -$279000.0 in 2022, then surged by 126.88% to $75000.0 in 2023, then tumbled by 377.33% to -$208000.0 in 2024, then increased by 3.37% to -$201000.0 in 2025.
  • Business Quant data shows Change in Account Payables for TIVC at -$201000.0 in Q4 2025, $231000.0 in Q3 2025, and -$204000.0 in Q2 2025.